TuHURA Biosciences, Inc. (HURA)
NASDAQ: HURA · Real-Time Price · USD
2.850
+0.010 (0.35%)
At close: Jul 25, 2025, 4:00 PM
2.800
-0.050 (-1.75%)
After-hours: Jul 25, 2025, 7:56 PM EDT
TuHURA Biosciences Stock Forecast
Stock Price Forecast
The 2 analysts that cover TuHURA Biosciences stock have a consensus rating of "Strong Buy" and an average price target of $11.5, which forecasts a 303.51% increase in the stock price over the next year. The lowest target is $11 and the highest is $12.
Price Target: $11.5 (+303.51%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 16, 2025.
Analyst Ratings
The average analyst rating for TuHURA Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +321.05% | May 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $13 → $12 | Strong Buy | Maintains | $13 → $12 | +321.05% | Apr 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $13 | Strong Buy | Initiates | $13 | +356.14% | Mar 3, 2025 |
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +285.96% | Dec 19, 2024 |
Financial Forecast
Revenue This Year
21.44M
from 34.52M
Decreased by -37.91%
Revenue Next Year
36.26M
from 21.44M
Increased by 69.15%
EPS This Year
-0.56
from -1.21
EPS Next Year
-0.49
from -0.56
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | 22.1M | 71.1M | |||
| Avg | n/a | 7.2M | 34.5M | |||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | 892.3% | |||
| Avg | - | - | 382.0% | |||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.44 | -0.29 | 0.30 |
| Avg | -0.56 | -0.49 | -0.18 |
| Low | -0.64 | -0.63 | -0.63 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.